Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

2000 ◽  
Vol 87 (5) ◽  
pp. 724-727 ◽  
Author(s):  
C. Boni ◽  
G. Bisagni ◽  
L. Savoldi ◽  
G. Moretti ◽  
E. Rondini ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Research ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung

scholarly journals A Phase II Study of Nivolumab in Patients With Advanced Non–small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L)

2019 ◽  
Vol 20 (2) ◽  
pp. 139-141 ◽  
Author(s):  
Hiroaki Akamatsu ◽  
Shunsuke Teraoka ◽  
Yasuhiro Koh ◽  
Takeharu Yamanaka ◽  
Nobuyuki Yamamoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung

scholarly journals Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non–Small Cell Lung Cancer: West Japan Thoracic Oncology Group 3505

2008 ◽  
Vol 14 (16) ◽  
pp. 5250-5254 ◽  
Author(s):  
Isamu Okamoto ◽  
Takashi Nishimura ◽  
Masaki Miyazaki ◽  
Hiroshige Yoshioka ◽  
Akihito Kubo ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Combination Therapy ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Oncology Group ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document